Decheng Capital Management Iii (Cayman), LLC Adicet Bio, Inc. Call Options Transaction History
Decheng Capital Management Iii (Cayman), LLC
- $181 Million
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACET
# of Institutions
107Shares Held
69.5MCall Options Held
13.3KPut Options Held
24.6K-
Orbimed Advisors LLC San Diego, CA11.4MShares$13.2 Million0.61% of portfolio
-
Tang Capital Management LLC San Diego, CA6.41MShares$7.37 Million1.83% of portfolio
-
Balyasny Asset Management LLC Chicago, IL6.18MShares$7.11 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY4.13MShares$4.75 Million0.16% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.11MShares$4.72 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $46M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...